Agomelatine is a melatonin receptor agonist and 5-HT2C receptor antagonist. It is used to treat depression in adults.
*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p><strong>Agomelatine</strong> (CAS: <strong>157269-07-5</strong>) is a melatonin receptor agonist and serotonin antagonist used in pharmaceutical synthesis. Its core manufacturing process involves the condensation of naphthalene derivatives with specific acylating agents under controlled catalytic conditions.</p>
<h3>Application</h3>
<ul>
<li>Major pharmaceutical production for treating major depressive disorder.</li>
<li>R&D applications in circadian rhythm regulation studies.</li>
<li>Custom API synthesis for global generic drug manufacturers.</li>
</ul>
<h3>Precautions</h3>
<p>Strict hepatotoxicity monitoring is required during clinical use. Storage must be maintained below 25°C in a dry, well-ventilated area away from direct sunlight to ensure chemical stability.</p>